Recent studies have demonstrated that mutations in endothelial PAS domain-containing protein 1 (EPAS1) is associated with manifestations of phaeochromocytomas and paragangliomas [1,9,12,13,14]. The gene discussed is EPAS1; the disease is pheochromocytoma.